Tat-M2NX TFA
Tat-M2NX is a cell-permeable peptide antagonist of TRPM2 that inhibits H2O2-induced Ca2+ influx in vitro (25-100 μM) . In vivo, it reduces infarct volume in male MCAO stroke models when administered pre- or 3h-post occlusion, showing utility in ischemia and oxidative stress research.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
4354.20
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
11722126 3x 1.0µg DNA
ALDH18A1 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
MBS1122327-01 0.5 mg (E-Coli)
Recombinant Human cytomegalovirus Uncharacterized protein UL27 (UL27), partial
Sign In for Pricing
View Details MBS1122327-02 0.05 mg (Baculovirus)
Recombinant Human cytomegalovirus Uncharacterized protein UL27 (UL27), partial
Sign In for Pricing
View Details MBS1122327-03 0.05 mg (Mammalian-Cell)
Recombinant Human cytomegalovirus Uncharacterized protein UL27 (UL27), partial
Sign In for Pricing
View Details MBS1122327-04 0.5 mg (Yeast)
Recombinant Human cytomegalovirus Uncharacterized protein UL27 (UL27), partial
Sign In for Pricing
View Details MBS1122327-05 1 mg (E-Coli)
Recombinant Human cytomegalovirus Uncharacterized protein UL27 (UL27), partial
Sign In for Pricing
View Details